Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | AGER | Q15109 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.42 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.42 |
| ▸ | PARP1 | P09874 | 1/20 | 0.39 |
| ▸ | DHODH | Q02127 | 2/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 2-Mercaptonicotinic Acid SCHEMBL261186 | 0.81 | KDM4E (0.63) | SMN1; SMN2LMNAKDM4ETDP1ALDH1A1 | |
| 2-Mercaptonicotinic Acid SCHEMBL29382089 | 0.81 | KDM4E (0.63) | SMN1; SMN2LMNAKDM4ETDP1ALDH1A1 | |
| SCHEMBL4620997 | 0.81 | KDM4E (0.47) | SMN1; SMN2LMNAKDM4ETDP1ALDH1A1 | |
| SCHEMBL1326787 | 0.79 | PARP1 (0.56) | SMN1; SMN2LMNAKDM4ETDP1ALDH1A1 | |
| 2-Mercaptonicotinic Acid SCHEMBL30605292 | 0.79 | KDM4E (0.61) | SMN1; SMN2LMNAKDM4ETDP1ALDH1A1 | |
| 2-Mercaptonicotinic Acid SCHEMBL29105774 | 0.79 | KDM4E (0.61) | SMN1; SMN2LMNAKDM4ETDP1ALDH1A1 | |
| SCHEMBL19017652 | 0.79 | SMN1; SMN2 (0.47) | SMN1; SMN2LMNAKDM4ETDP1ALDH1A1 | |
| 2-Mercaptonicotinic Acid SCHEMBL29181672 | 0.79 | KDM4E (0.61) | SMN1; SMN2LMNAKDM4ETDP1ALDH1A1 | |
| SCHEMBL27951997 | 0.79 | KDM4E (0.45) | SMN1; SMN2LMNAKDM4ETDP1ALDH1A1 | |
| SCHEMBL3263627 | 0.78 | KDM4E (0.65) | SMN1; SMN2LMNAKDM4ETDP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220380383-A1 | NEUROPROTECTIVE PDI MODULATING SMALL MOLECULES AND METHODS OF USE THEREOF | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 2022-12-01 | — | — | US | disclosed |
| WO-2020113222-A1 | NEUROPROTECTIVE PDI MODULATING SMALL MOLECULES AND METHODS OF USE THEREOF | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2020-06-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220380383-A1 | NEUROPROTECTIVE PDI MODULATING SMALL MOLECULES AND METHODS OF USE THEREOF | NLN, PDIA5, PRNP | SMN1; SMN2 30/4885LMNA 1545/4885KDM4E 4626/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.